Weekly Twitter Roundup
Posted by Dan Vorhaus on January 29, 2010
Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:
- Healthcare hacks on the rise. Attacks doubled in Q4 thanks to sensitive data, “large attack surfaces”: http://bit.ly/d0izMg
- Life Technologies Fires Latest Sequencing Salvo: http://bit.ly/dspF0d
- RT @Berci: Microsoft HealthVault and Siemens Bringing PHR Platform to Germany – And a Look at a German EHR http://ff.im/-f0mQ3
- RT @matthewherper: Gene machine wars get hotter, hotter, hotter: http://bit.ly/copmcc
- RT @GenomeWeb_News Life Technologies, Ignite Institute Team on Sequencing; Ignite Buys 100 New SOLiD Systems http://bit.ly/bWzSAt
- The future of PGx/Dx? @Duncande uses iPS cells -> genetically matched heart cells -> test heart drugs for toxicity http://bit.ly/Vme2m
- HealthVault Revolution Health shutting down PHR-what happens to consumer health data? http://bit.ly/bnDnjM (RT @john_chilmark)
- Bench to Market tackles the ins & outs of “Raising Private Capital”: http://bit.ly/c494IK How to get funded w/out going to jail.
- RT @DukeIGSP: In GenomeWeb poll, 44% say ACLU will win Myriad gene patenting case; 26% predict Myriad will win.
- RT @EdwardWinstead: Wash U will sequence 1,200 genomes in 3 yrs: “This is all whole-genomes, all the time” http://bit.ly/cr4NCd
- RT @wellcometrust: 10 yrs ago today: 1st release of the Ensembl genome browser, giving genomics researchers a leg up http://bit.ly/cYd5yx
- RT @lukejostins: My take on the ‘syntheic association’ paper & surrounding press: David Goldstein Proves Himself Wrong http://bit.ly/dzD8O4
- Quest CEO Promises ‘More and More’ Esoteric, Genetic Tests to Emerge: http://bit.ly/beK5TR (via @GW_The_Sample)
- Myriad/ACLU gene patent litigation from @NatureNews New angle. Looks at exclusive patent licenses as tech transf sol’n: http://bit.ly/cuBkuh
- RT @EdwardWinstead: The cost, benefits & challenges of sequencing cancer genomes http://bit.ly/c0MbGN Dr. Elaine Mardis in @NCIBulletin
- The Next Health Care Debate: Digital Privacy: http://bit.ly/4GCFmL Surprise finding: Americans don’t trust gov’t with medical data
- Nevada hospital admits to prolonged patient privacy leak: http://bit.ly/cO4eNe #HIPAA #privacy
- Continuing to push the DTC Genomic Research Model RT @23andMe: Parkinson’s Research Initiative Progress Update: http://bit.ly/b0cbmB
- Compare UK reg to lack thereof in US: RT @PHGFoundation Inaccurate media portrayal of PGD for ‘minor’ genetic disorders http://bit.ly/cBD3bL
- RT @Berci: Personal Health Systems: A View from Across the Pond (a great analysis of quite a long analysis) http://ff.im/-eT2GI
- RT @girlscientist: The only geneticist who gets to comment on David Goldstein’s paper in the NYTimes story is Kari Stefansson. Shocked (x2)!
- “The hunt for the genetic roots of common diseases has hit a blank wall.” http://bit.ly/9iuhxB (NYT lede re: Goldstein GWAS/rare variants)
- Hiding place for missing heritability uncovered: http://bit.ly/52EsBs (from @NatureNews via Misha Angrist)
- WaPo article (last tweet) is nicely balanced, esp Bob Green’s quotes. When will we stop seeing the “introduction to DTC genetics” articles?
- RT @blaine_5: Wash. Post article today about personal genomics, includes @23andMe @decodegenetics @Navigenics – http://tinyurl.com/y86apey
- Gene screening to give your embryo the best start http://bit.ly/8E5NGm (discussing @Counsyl v @blaine_5) Commotion in comments no surprise.
- Sage Bionetworks opens Repository, first step toward open-access commons: http://bit.ly/4tYfFE
- Law Professors Contend that Data Exclusivity is Secondary Issue in Follow-on Biologics Debate: http://bit.ly/4x20Lx (v Patent Docs)
- RT @wellcometrust: Genetic research: The fight against disease gets personal. @RogerHighfield in the Telegraph: http://bit.ly/7oNOHX
- RT @paulblaser: DIY Bio: A Growing Movement Takes on Aging – http://ow.ly/10fEI
- CT doctors raise HIPAA/privacy concerns over United Health/HealthNet acquisition; CT AG to investigate: http://bit.ly/4weMgR
- Technical details re: the St. Jude’s/WashU Pediatric Cancer Genome Sequencing Collab from Dan Kobolt of MassGenomics: http://bit.ly/5mwK9D
- RT @patsycat21: Pediatric cancer genome project will sequence tumors from 600 children: http://tr.im/LyZL
- RT @gw_dailyscan: It’s Personal: Esther Dyson discusses personalized medicine, as does the Boston Globe. http://bit.ly/6BgDas
- Meet the New deCODE, Same as the Old deCODE? http://bit.ly/57Hv5W
- RT @blaine_5: RT @bmahersciwriter: NY to allow using DNA databases to identify suspects through their relatives http://is.gd/6ZV41
- RT @ldtimmerman: CA-based Helixis, like PC companies of old, seeks to put desktop genomics tool on every lab bench. http://bit.ly/8XUWbQ
- Making Personalized Medicine Pay: http://bit.ly/7Ux2QH BusinessWeek w/ a good overview of how PBMs (Medco, Gen Health) embrace PM
- Personal genomics getting serious: Counsyl emerging from stealth mode: http://bit.ly/8h7Dse (via @dgmacarthur) What about cost of PGD/IVF?
- Pharma + politics. German CER director ousted for taking too tough a stand? http://bit.ly/8hJgvL (via @ScienceInsider)
- Shopping for your Genome: “consumer” genomics and why HolGenTech is not ready for primetime: http://bit.ly/6Q80XI
- BusinessWeek offers a high-level comparison of DTC services from @decodegenetics @23andMe and @Navigenics http://bit.ly/6loYMS
- RT @dgmacarthur: The challenge of self-reported phenotype data – people are hypochondriacs: http://j.mp/5WF0df
- RT @blaine_5, @USLawUpdates: Senate Judiciary Committee Passes Bill Banning Pay-for-Delay Settlements on Generic Drugs http://bit.ly/7S69yt
- EdwardWinstead RT @EdwardWinstead First time I’ve seen “next-generation” used to describe biorepositories. http://bit.ly/7wHgrQ
Filed under: General Interest, Industry News
Dan -
I’d just like to point out that the GenomeWeb poll on ACLU v. Myriad reported the following results:
44% The ACLU will win; gene patents stifle research.
26% Myriad will win; the patents cover intellectual property.
18% It’s a nuisance case and should be dismissed.
10% What gene patenting case?
Note that if you add the middle two categories, which basically represent the same opinion, you get exactly 44% (so 50/50 split) – so my next question is, who reads and answers these polls? (I, for one, read but don’t answer)
Thanks for the Twitter Roundup!